Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

The recent introduction of the “precision medicine” concept in oncology pushed cancer research to focus on dynamic measurable biomarkers able to predict responses to novel anticancer therapies in order to improve clinical outcomes. Recently, the involvement of extracellular vesicles (EVs) in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Brocco, D., Lanuti, P., Simeone, P., Bologna, G., Pieragostino, D., Cufaro, M. C., Graziano, V., Peri, M., Di Marino, P., De Tursi, M., Grassadonia, A., Rapposelli, I. G., Pierdomenico, L., Ercolino, E., Ciccocioppo, F., Del Boccio, P., Marchisio, M., Natoli, C., Miscia, S., Tinari, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885781/
https://www.ncbi.nlm.nih.gov/pubmed/31827511
http://dx.doi.org/10.1155/2019/5879616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885781/
https://www.ncbi.nlm.nih.gov/pubmed/31827511
http://dx.doi.org/10.1155/2019/5879616

Ejemplares similares